• About
  • Contact
  • Testimonials
  • Newsletter
  • More
    • Demographics & Advertising Rates
    • Terms & Conditions
Tuesday, August 9, 2022
No Result
View All Result
CALIFORNIA BUSINESS JOURNAL
  • Front Page
  • Business
  • Finance
  • People
  • Featured
  • Opinion
  • Technology
  • Law
  • News
  • Food
  • Art & Culture
  • Human Interest
  • Education
  • Insurance
  • Real Estate
  • Health & Fitness
CALIFORNIA BUSINESS JOURNAL
Prescription Drug Costs

Commentary: How To Get To Lower RX Costs. Prescription Drugs Are The Fastest Growing Cost Driver In Healthcare.

by Paul Seegert, Special to California Business Journal
A A
Share on FacebookShare on Twitter

When we evaluate health plans, we consistently see that prescription drugs are the fastest growing cost driver in healthcare. So, I was excited to see that California Governor Gavin Newsom, on September 28, 2020, signed legislation that is intended to lower prescription drug costs for Californians. Then I read the bill — yes I actually read it — and the excitement went away. What can we expect from this in our day to day lives? And how soon?

Consider some of these key components of the new law:

“The bill would require The California Health and Human Services Agency to enter into partnerships to produce or distribute distribute generic prescription drugs and at least one form of insulin.”

It doesn’t take a degree in healthcare — just a quick Google search — to realize that one of the reasons that this law was able to make it through is the fact that it is targeting the smallest revenue generator for drug companies – generics. It leaves out specialty and brand drugs – the biggest contributor to increased costs and 80% of overall drug costs in most plans.

According to the bill, it “would, subject to appropriation by the Legislature, require CHHSA to submit a report to the Legislature on or before July 1, 2023, that, among other things, assesses the feasibility and advantages of directly manufacturing generic prescription drugs and selling generic prescription drugs at a fair price.”

Based upon this part of the bill, we will not know until 2023 whether it is deemed feasible for the state to get into the generic drug business. So, no changes are expected soon.

According to the bill: “The bill would exempt all nonpublic information and documents relating to this program from disclosure under the California Public Records Act in order to protect proprietary, confidential information regarding manufacturer or distribution costs and drug pricing, utilization and rebates.”

One of the largest contributing factors to the high cost of healthcare in our country is the systemic lack of transparency. In fact, in prescription drug distribution, there are 32 ways that the supply chain adds cost to a drug before it gets to the member. This bill specifically maintains that secrecy. And the same is true for the meetings that will be held – as it requires that they be private.

Paul Seegert is Managing Partner at PCS Advisers
Paul Seegert is Managing Partner at PCS Advisers

In summary, this new law will not do much to change the trajectory of drug prices in CA or around the country. Here are three points that would drastically lower drug prices:

Step One: End Rebates

Rebates are dollars that are paid to different players in the supply chain to get the drug added to the list that members can access with their insurance – the formulary. In many prescriptions, rebates account for 20-30% of the price that we pay when accessing them through our health coverage. Rebates can be as high as 60%. Insulin is a prime example. Millions of Americans rely on prescriptions like Lilly’s Humalog to manage their diabetes. A box costs $550, $330 is the rebate and that leaves $220 as the actual price without the rebate. Lilly manufactures its own “authorized generic” of Humalog: Insulin Lispro. The generic sells for $250 and does not have a rebate. So, they make more from the generic than the brand.

Step Two: Allow Fair Cash Pricing

Pharmacies that take insurance — basically all pharmacies — are contractually prohibited from offering a cash price with a fair margin to consumers. These pharmacies are not allowed to offer a cash price that is cheaper than the “discounted” price that members get by using their insurance – even though many drugs would be dirt cheap if this were allowed. Take Montelukast (generic Singulair for asthma/allergies) as an example. The “cash price” that pharmacies can charge by their contracts is $400 for a 90-day supply. The “discounted/insurance price” is $25 for a 90-day supply and the “fair cash price” is $34.50 for an entire year supply. Put another way, price per pill of the original cash price is $4.44 vs $0.095 fair cash price

Step Three: Fix Orphan Drug Rules

In 1983, the Orphan Drug Act was passed to encourage research and development of drugs that would treat rare diseases — typically affecting less than 200,000 people in the U.S. The thinking was that without special incentives, manufacturers would not invest in these areas and treatments wouldn’t be developed. So, tax incentives and market exclusivity were created. How has it worked out?

Orphan drugs have become an area where manufacturers can innovate more cheaply using private and federal dollars, have longer exclusivity and the ability to charge just about any amount. If you can charge $50,000 or more per month for a drug it doesn’t matter that the customer base is smaller in overall numbers. In fact, of the 48 new drugs approved by the FDA in 2019, 27 were orphan drugs.

Hypophosphatasia (HPP) is a rare and serious condition that affects mineralization in the bones and teeth. There are 500-600 known cases in the U.S. In 2015, the FDA approved an orphan drug Strensiq for the treatment of HPP. The price tag can easily be $2,300,000 based on a person’s size.

There are many examples around the country where individual employers are addressing these three areas at their plan level. The results – 68% lower prescription costs for their plan and their members.

This article was written by Paul Seegert, with Paul Pruitt.

Click here to read the article on Governor Newsom Signing Legislation to Advance California’s Fight to Lower Prescription Drug Prices.

ADVERTISEMENT

Paul Seegert is Managing Partner at PCS Advisers.

Paul Pruitt is CEO of SHARx.

This article was edited and published by Rick Weinberg, California Business Journal’s Founder and Editor-in-Chief. Click here for Rick Weinberg’s biography.

 

Tags: CACaliforniaCEOconsumersdevelopmentdiscounteddrug pricesdrugsGovernor NewsomhealthhealthcareHow To Get To Lower RX Costsinformationinsurancelawlow prescription costsLower RX CostsmanufacturingPaul SeegertPCS Adviserspharmaciestagtaxtransparencytreatment
ADVERTISEMENT
Paul Seegert, Special to California Business Journal

Paul Seegert, Special to California Business Journal

Related Posts

How Teachers Can Help Students With Diabetes
How Teachers Can Help Students With Diabetes
How Healthcare Providers Utilize Twitter Effectively
How Healthcare Providers Utilize Twitter Effectively
Why you need health insurance
How Healthcare Companies Can Meet Regulatory Compliance
How To Choose The Right Medical Care For Your Family
How To Choose The Right Medical Care For Your Family
Nick Mathews
A Long Journey with Addiction, Recovery, and Finding Peace through Helping Others
pharmacy-benefit-managers
APC's Common Sense on PBMs
advertisement

CBJ Newsletter

Facebook Twitter LinkedIn Instagram LinkedIn

Advertise With CBJ

1REALTOUR-SAN DIEGO-WEB DESIGN
Facebook Twitter LinkedIn LinkedIn Instagram
C B J   LOGO  SVG-01
  • About
  • Contact California Business Journal
  • Testimonials
  • Demographics & Advertising Rates
  • Terms & Conditions

Categories

  • Art & Culture
  • Business
  • Daily Updates
  • Editor's Choice
  • Education
  • Featured
  • Finance
  • Food & Dining
  • Health & Fitness
  • Human Interest
  • Insurance
  • Law
  • Lawyers
  • Marketing
  • Medical
  • News
  • Newsletter
  • Opinion
  • People
  • Popular
  • Real Estate
  • Social Media
  • Technology
  • Uncategorized

CBJ Partner Firebrand Media

Laguna Beach Independent Newspaper
 Laguna Beach City Guide
 Newport Beach Independent Newspaper
Newport Beach Country Club Magazine
  Montage Magazine
 Omni Escapes Hotel Magazine
 Bespoke Concierge New York
 Evans Hotels
 Laguna Beach Magazine
 On The Menu Laguna Beach
 Newport Beach Magazine
Coastal Real Estate Guide (NB,LB, CDM)
Monarch Beach Resort Magazine
 Pacific Coast Magazine (SoCal)
Sea Island Life Magazine
Salamander Hotel & Resorts Magazine
 View our entire portfolio

 

Most Viewed

  • Gavel, scales of justice and law books

    Lawsuit Basics: How Much Does It Cost to Sue Someone?

    0 shares
    Share 0 Tweet 0
  • The Impact of Covid: Racing to Buy Second Citizenships

    3 shares
    Share 0 Tweet 0
  • What to Do When an Online Casino Refuses to Pay Out Your Winnings

    0 shares
    Share 0 Tweet 0
  • NFL Paychecks: How Do NFL Players Get Paid?

    0 shares
    Share 0 Tweet 0
  • Five Reasons Why The Government Does Not Like Bitcoin

    0 shares
    Share 0 Tweet 0
  • Investigation: Can TriumphFX Take Your Money?

    0 shares
    Share 0 Tweet 0
  • New Study: California’s 10 Universities That Produce the Most CEOs

    0 shares
    Share 0 Tweet 0
  • How to Start a Telecommunication Business: A Step-By-Step Guide

    0 shares
    Share 0 Tweet 0
  • Best Crypto Faucets You Can Try In 2021 and 2022

    0 shares
    Share 0 Tweet 0
  • The Only Way

    0 shares
    Share 0 Tweet 0

Latest Articles

The Financial Milestones You Need to Hit Before Starting a Family

The Financial Milestones You Need to Hit Before Starting a Family

How To Choose Unique Promise Ring For Her?

How To Choose Unique Promise Ring For Her?

5 Tips to Prepare for a Day Out Playing Golf

5 Tips to Prepare for a Day Out Playing Golf

Bitcoin Founder Satoshi Nakamoto. Photo credit: CBC

The Mystery Man: Bitcoin Founder Satoshi Nakamoto

cybersecurity

What is BYOD Policy?

machining operation

What Are Speed and Feed Calculators Used For?

Keep Your Brain-Body Connection Sharp with Algae Supplements

Keep Your Brain-Body Connection Sharp with Algae Supplements

contractor

Planning to Get a Contractor License? 7 Things You Should Consider First

penny stocks

What are the pros and cons of investing in penny stocks?

Vaping

Why the Vaping Industry Has Snowballed in 20 Years

California Business Journal | California Business News, California News Media, California business articles | Orange County, Los Angeles, San Diego, Inland Empire, Northern California, San Francisco | Huntington Beach CA 92649 | (949) 648-3815
ALL RIGHTS RESERVED BY CALIFORNIA BUSINESS JOURNAL.
Site Design by 1REALTOUR

No Result
View All Result
  • Front Page
  • Business
  • Finance
  • People
  • Featured
  • Opinion
  • Technology
  • Law
  • News
  • Food
  • Art & Culture
  • Human Interest
  • Education
  • Insurance
  • Real Estate
  • Health & Fitness

California Business Journal | California Business News, California News Media, California business articles | Orange County, Los Angeles, San Diego, Inland Empire, Northern California, San Francisco | Huntington Beach CA 92649 | (949) 648-3815
ALL RIGHTS RESERVED BY CALIFORNIA BUSINESS JOURNAL.
Site Design by 1REALTOUR